176 related articles for article (PubMed ID: 12468175)
1. The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.
Ravin AJ; Edwards RP; A Krohn M; Kelley JR; Christopherson WA; Roberts JM
Obstet Gynecol; 2002 Dec; 100(6):1285-9. PubMed ID: 12468175
[TBL] [Abstract][Full Text] [Related]
2. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
Spannagl M; Heinemann LA; Schramm W
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
Heraudeau A; Delluc A; Le Henaff M; Lacut K; Leroyer C; Desrues B; Couturaud F; Tromeur C
PLoS One; 2018; 13(5):e0194973. PubMed ID: 29775482
[TBL] [Abstract][Full Text] [Related]
5. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
Haim N; Lanir N; Hoffman R; Haim A; Tsalik M; Brenner B
Am J Med; 2001 Feb; 110(2):91-6. PubMed ID: 11165549
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
9. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
[TBL] [Abstract][Full Text] [Related]
10. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
Middeldorp S; Henkens CM; Koopman MM; van Pampus EC; Hamulyák K; van der Meer J; Prins MH; Büller HR
Ann Intern Med; 1998 Jan; 128(1):15-20. PubMed ID: 9424976
[TBL] [Abstract][Full Text] [Related]
11. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
Rodeghiero F; Tosetto A
Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
[TBL] [Abstract][Full Text] [Related]
13. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
[TBL] [Abstract][Full Text] [Related]
16. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive.
DiSiena MR; Intres R; Carter DJ
Am J Forensic Med Pathol; 1998 Dec; 19(4):362-7. PubMed ID: 9885932
[TBL] [Abstract][Full Text] [Related]
19. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]